{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:11:49Z","timestamp":1726492309092},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jns.2006.10.010","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T16:26:52Z","timestamp":1164817612000},"page":"62-66","source":"Crossref","is-referenced-by-count":16,"title":["A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis"],"prefix":"10.1016","volume":"252","author":[{"given":"J.","family":"Kalita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vijaykumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Palit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2006.10.010_bib1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/jnnp.57.12.1484","article-title":"Radiological and neurophysiological changes in Japanese encephalitis","volume":"57","author":"Misra","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.10.010_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s004150050090","article-title":"Movement disorders in Japanese encephalitis","volume":"244","author":"Misra","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2006.10.010_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/pmj.78.918.238","article-title":"Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only","volume":"78","author":"Misra","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jns.2006.10.010_bib4","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/archneur.60.12.1760","article-title":"A comparison of clinical and radiological findings in adults and children with Japanese encephalitis","volume":"60","author":"Kalita","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.10.010_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","article-title":"The brain-stem lesions in parkinsonism","volume":"16","author":"Greenfield","year":"1953","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.10.010_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01252019","article-title":"Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome","volume":"41","author":"Riederer","year":"1977","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2006.10.010_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/appi.neuropsych.13.2.222","article-title":"In vivo evidence for differential association of striatal dopamine and midbrain serotonin system with neuropsychiatric symptoms in Parkinson's disease","volume":"13","author":"Murai","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jns.2006.10.010_bib8","first-page":"227","article-title":"Etiology of Parkinson's disease contributions from 18F-Dopa positron emission tomography","volume":"80","author":"Piccini","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2006.10.010_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[131]FP-SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease","volume":"62","author":"Booij","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.10.010_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archneur.1995.00540270025015","article-title":"Cerebrospinal homovanillic acid in DATATOP study on Parkinson's disease","volume":"52","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.10.010_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1531-8257(200011)15:6<1168::AID-MDS1016>3.0.CO;2-V","article-title":"Markedly severe dystonia in Japanese encephalitis","volume":"15","author":"Kalita","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.10.010_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11064-005-7414-2","article-title":"Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders","volume":"30","author":"Misra","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2006.10.010_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/brain\/96.2.277","article-title":"catecholamine concentration in CSF and plasma of patients with cerebral infarction and haemorrhage","volume":"96","author":"Meyer","year":"1973","journal-title":"Brain"},{"key":"10.1016\/j.jns.2006.10.010_bib14","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1136\/jnnp.52.Suppl.96","article-title":"Clinical variants of idiopathic torsion dystonia","author":"Fahn","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2006.10.010_bib15","series-title":"Recent developments in Parkinson's disease","first-page":"153","article-title":"Unified Parkinson's disease rating scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.jns.2006.10.010_bib16","series-title":"Progress in Alzhimer's and Parkinsons diseases","first-page":"363","article-title":"A pathophysiology of hereditary progressive dystonia with marked diurnal fluctuation: its characteristics in contrast to other dopa responsive disorders","author":"Segawa","year":"1998"},{"key":"10.1016\/j.jns.2006.10.010_bib17","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1212\/WNL.42.11.2111","article-title":"Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group","volume":"42","author":"LeWitt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.10.010_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06004850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06004850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T03:00:01Z","timestamp":1547175601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06004850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022510X06004850"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2006.10.010","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}